Home >Company Profile
Management Philosophy

management philosophy

Company Profile
Company Profile SBI Pharmaceuticals Co., Ltd. is a leading company specialized in R&D and manufacture of 5-ALA (5-aminolevulinic acid) based products, and conducting operations to provide 5-ALA-based products in the fields of medicines, medical devices, cosmetics and health foods.
Company Name
SBI Pharmaceuticals Co., Ltd.
Business Overview R&D, manufacture and marketing of the medicines, medical devices, cosmetics and health foods utilizing 5-ALA (5-aminolevulinic acid)
Company Address
(Head Office)
Izumi Garden Tower 20F, 1-6-1, Roppongi, Minato-ku, Tokyo 106-6020, Japan

TEL:+81(3)6229 0095  FAX:+81(3)3589 0761
Access Direct link with Roppongi 1-chome Station, Namboku Line, Tokyo Metro
Contact Please contact us from here.
Kawasaki Research Institute Innovation Center of NanoMedicine (iCONM) 4F, 3-25-14 Tono-machi, Kawasaki-ku
Kawasaki-shi, Kanagawa 210-0821, Japan

Tel:+81(44) 382 0500  Fax:+81(44) 382 0510
Bahrain Representative Office Office No. 191, 14th Floor, Platinum Tower,
Building No. 190, Road No. 2803, Block 428, Seef District, Kingdom of Bahrain
Tel:+973 13100055  Fax:+973 13116066
Date Founded April 18, 2008
Capital
as of September 30, 2018
100 million yen
Shareholders
as of September 30, 2018
SBI Group 86.17%
Cosmo Energy Holdings Co., Ltd. 13.83%
*The share of "SBI Group" is the total of the voting rights of the subsidiary and the funds of SBI Holdings, Inc.based on the International Financial Reporting Standards.
Management
as of September 30, 2018
Representative Director,
President
Yoshitaka Kitao
Representative Director,
Executive Vice President
Ulrich Kosciessa
Director, Executive Officer CTO
Tohru Tanaka
Director, Executive Officer CFO
Kenji Hirai
Director, Executive Officer CSO
Motowo Nakajima
Director, Executive Officer
Masahiro Ishizuka
Director, Executive Officer
Masahiro Takeoka
Director
Masahiro Kami
Director
Takashi Nakagawa
Statutory Auditor
Hideyuki Katsuchi
Statutory Auditor
Toshiyuki Mizui
Statutory Auditor
Shumpei Morita

Here is a PDF file of Company Profile.

History               
2008 April SBI ALApromo Co., Ltd. established
2009 June ALApharma GmbH established, a joint venture with medac GmbH in Germany
2011 June ALAplus Laboratory established, an organization broadcasting R&D information on ALA
2012 April Changed to the current company name of SBI Pharmaceuticals Co., Ltd.
Transferred domestic sales and marketing operations of cosmetics and food supplements to a newly established company named SBI ALApromo Co., Ltd.
2012 October SBI Bahrain Office established
2013 March Dawani SBI Trading Company W.L.L. established, a joint venture with Dawani Group Holding
2013 September "ALAGLIO Oral 1.5g" launched, an orally administered agent for photodynamic diagnosis
2014 April Medical light source "Bi-color LED light source Aladuck LS-DLED" launched
2015 February Medical light source "Violet LD light source Alcedo LS-VLD" launched
2016 April Medical video camera for endoscope "Ultra High Sensitivity CMOS Camera System for Endoscope Alaowl" launched
2017 January Japan Bio-Venture Award, the Prize of Minister of Economy, Trade & Industry received
2017 February Tejima Seiichi Commemorative Research Award, the Prize of Invention received
2017 December "ALAGLIO Divided Granules 1.5g" launched, an orally administered agent for photodynamic diagnosis
2018 March Relocation of Research Institute to Kawasaki-shi
Page Top